Proton pump inhibitor therapy
Partial response to proton pump inhibitor therapy for GERD: observational study of patient characteristics, burden of disease, and costs in the USA
... revolutionized the management of symptoms among patients with GERD, it remains commonplace to find patients with persistent symptoms despite what treating physicians con- sider to be optimized PPI therapy. Many ...
11
Evaluation of costs accrued through inadvertent continuation of hospital-initiated proton pump inhibitor therapy for stress ulcer prophylaxis beyond hospital discharge: a retrospective chart review
... patients. Proton pump inhibitor (PPI)-based stress ulcer prophylaxis (SUP) has been widely prescribed in noncritically ill patients who are at low risk for clinically significant bleeding, which is ...
9
Perceptions of patient-centered care among veterans with gastroesophageal reflux disease on proton pump inhibitor therapy
... PPI therapy perceive care, and (2) harnessing patient perspectives that can be used to optimize care experiences to better align with the unique needs and preferences within this ...
13
Micronutrient Consequences of Long Term Proton Pump Inhibitor Therapy
... Other areas of concern have been hyponatraemia[5],hypokalaemia[6],renalimpairm- ent [7], development of microscopic colitis [8], carcinoid formation [9], small bowel bacterial overgrowth [10][11], enteric infections ...
7
<p>Combined administration of antibiotics increases the incidence of antibiotic-associated diarrhea in critically ill patients</p>
... of proton pump inhibitors and hypoproteinemia are associated with AAD and that in particular, there is a signi fi cant correlation with the recurrence of ...of proton pump inhibitors or albumin ...
8
Proton pump inhibitor-refractory gastroesophageal reflux disease: challenges and solutions
... Another novel procedure for refractory GERD is LES elec- trical stimulation therapy (EST), which has been used for treating GI motility disorders. The LES stimulation system consists of an implantable pulse ...
16
Vonoprazan-based triple therapy is non-inferior to susceptibility-guided proton pump inhibitor-based triple therapy for Helicobacter pylori eradication
... triple therapy group than the culture-guided ...triple therapy [11], the eradication rate was ...longer therapy is recom- mended to obtain a sufficient eradication rate in patients with triple ...
7
Risk management of risk management: Combining proton pump inhibitors with low-dose aspirin
... antithrombotic therapy, concurrent NSAIDs or corticosteroids, and infection with ...or proton-pump ...a proton-pump inhibitor should be considered to reduce the gastrointestinal ...
14
Gastric Mucosal Atrophy Might Be Associated with the Efficacy of First Line Therapy Using Vonoprazan for Helicobacter pylori
... first-line therapy according to patients’ age, years of admin- istration Differences in the rate of first-line eradication therapy for ...VPZ therapy had the highest eradication rate in all age ...
17
Esophageal Strictures during Treatment with a Proton Pump Inhibitor
... of proton pumps inhibitors (PPI), the gastroeso- phageal reflux disease (GERD) induced stricture has shown significant improvement but the chemotherapy in- duced strictures show poor response and its treatment is ...
7
A Review on Proton Pump Inhibitor for The Treatment of Peptic Ulcer
... PPIs and other antisecretory agents cause Hypergastrinemia by inhibiting gastric acid secretion. The rise in serum gastrin levels is usually modest. The elevated gastrin values return to normal Within 4 weeks after PPI ...
11
Proton pump inhibitor chemosensitization in human osteosarcoma: from the bench to the patients’ bed
... combination therapy is responsible for the failure of the systemic chemotherapy treatment ...chemo- therapy dose-intensification [9] or the preoperative deliver of intra-arterial cisplatin [10,11] are able ...
7
The association between celiac disease and eosinophilic esophagitis in children and adults
... The diagnosis of both EoE and CD was made in three patients, all of whom were males in the pediatric age group. No adults were diagnosed with both conditions. The pertinent clinical, endoscopic and histological de- tails ...
6
Pleiotropic effect of the proton pump inhibitor esomeprazole leading to suppression of lung inflammation and fibrosis
... anti-reflux therapy (of whom over 90% were on PPIs) ...anti-reflux therapy was also associated with fewer epi- sodes of acute exacerbations compared to IPF patients who did not take these medications ...
20
CYP2C19 Phenotype and Risk of Proton Pump Inhibitor–Associated Infections
... In this retrospective cohort of 670 infants and children treated with PPIs, CYP2C19 NMs had more frequent infections in the year after starting therapy than did CYP2C19 RM/UMs. The previously observed differences ...
10
Non antibiotic therapy for mycobacterium tuberculosis infection
... of therapy, marked drug toxicity, failure of the patient to complete the prescribed ...2] proton pump inhibitor like Lansoprazole 3] Antihypertensive like L type calcium channel blocker ...
7
High dose lansoprazole combined with metronomic chemotherapy: a phase I/II study in companion animals with spontaneously occurring tumors
... of proton pumps is increased in chemoresistant phenotypes and further increased by anticancer drugs as well ...[24]. Proton pump inhibitors have been shown to be highly effective in inhibiting ...
10
EFFECT OF ANTIREFLUX THERAPY ON THE VOICE OUTCOMES OF PHONOMICROSURGERY FOR VOCAL FOLD POLYPS
... antireflux therapy in the form of PPI and sodium alginate, on the voice outcome after phonomicrosurgery of vocal fold ...antireflux therapy in the form of proton pump inhibitors (omeprazole ...
9
Short-term triple therapy with azithromycin for Helicobacter pylori eradication: Low cost, high compliance, but low efficacy
... Background: The Brazilian consensus recommends a short-term treatment course with clarithromycin, amoxicillin and proton-pump inhibitor for the eradication of Helicobacter pylori (H. pylori). This ...
5
Download Download PDF
... Acid peptic disorder is a common entity presenting in daily clinical practice andis a significant burden to the society, due to chronicity. Since prime cause of this inflammation is H. pylori, key element in the success ...
6